HK1203767A1 - Lactobacillus reuteri dsm 17938 for the development of cognitive function dsm17938 - Google Patents

Lactobacillus reuteri dsm 17938 for the development of cognitive function dsm17938

Info

Publication number
HK1203767A1
HK1203767A1 HK15103997.0A HK15103997A HK1203767A1 HK 1203767 A1 HK1203767 A1 HK 1203767A1 HK 15103997 A HK15103997 A HK 15103997A HK 1203767 A1 HK1203767 A1 HK 1203767A1
Authority
HK
Hong Kong
Prior art keywords
dsm17938
development
cognitive function
lactobacillus reuteri
reuteri dsm
Prior art date
Application number
HK15103997.0A
Other languages
English (en)
Chinese (zh)
Inventor
加芙列拉．貝爾貢齊立-德蒙
馬加利．福爾
尼科爾．庫施
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab filed Critical Biogaia Ab
Publication of HK1203767A1 publication Critical patent/HK1203767A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/173—Reuteri
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pediatric Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15103997.0A 2011-12-30 2015-04-24 Lactobacillus reuteri dsm 17938 for the development of cognitive function dsm17938 HK1203767A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11196139.7A EP2609814A1 (en) 2011-12-30 2011-12-30 Lactobacillus reuteri DSM 17938 for the development of cognitive function
PCT/EP2012/074023 WO2013098033A1 (en) 2011-12-30 2012-11-30 Lactobacillus reuteri dsm 17938 for the development of cognitive function

Publications (1)

Publication Number Publication Date
HK1203767A1 true HK1203767A1 (en) 2015-11-06

Family

ID=47257835

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15103997.0A HK1203767A1 (en) 2011-12-30 2015-04-24 Lactobacillus reuteri dsm 17938 for the development of cognitive function dsm17938

Country Status (13)

Country Link
US (1) US20140363410A1 (es)
EP (2) EP2609814A1 (es)
JP (1) JP2015503913A (es)
KR (1) KR20140131505A (es)
CN (1) CN104185427A (es)
AU (1) AU2012361122A1 (es)
BR (1) BR112014015826A8 (es)
CA (1) CA2862001A1 (es)
HK (1) HK1203767A1 (es)
MX (1) MX2014008099A (es)
RU (1) RU2014131382A (es)
WO (1) WO2013098033A1 (es)
ZA (1) ZA201404824B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2998529B1 (fr) * 2012-11-26 2015-02-06 Renault Sa Procede et dispositif correspondant d'accouplement entre un arbre d'un moteur electrique et un arbre de roue d'un vehicule automobile a traction electrique ou hybride
US9241923B2 (en) 2013-07-16 2016-01-26 Mead Johnson Nutrition Company Methods for promoting neuronal development and/or health
US9226914B2 (en) 2013-07-16 2016-01-05 Mead Johnson Nutrition Company Methods for promoting neuronal development and/or health
WO2015134808A2 (en) 2014-03-06 2015-09-11 Research Institute At Nationwide Children's Hospital Probiotic formulations and methods for use
US10624934B2 (en) 2014-03-06 2020-04-21 Research Institute At Nationwide Children's Hospital Prebiotic formulations
WO2015160234A1 (en) * 2014-04-17 2015-10-22 N.V. Nutricia Composition for brain improvement
KR101656662B1 (ko) 2014-11-18 2016-09-12 한국생명공학연구원 2-옥소-1,2,3,4-테트라하이드로피리미딘-5-카르복사미드 유도체를 유효성분으로 함유하는 대사성 질환 예방 또는 치료용 약학적 조성물
EP3294308A4 (en) 2015-05-14 2019-03-06 University of Puerto Rico PROCESS FOR RECOVERING THE BIOZOOSE OF NEWBORN
EP3998072A1 (en) * 2015-05-22 2022-05-18 Arizona Board of Regents on behalf of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10617701B2 (en) * 2015-07-10 2020-04-14 Mead Johnson Nutrition Company Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
EP3322408B1 (en) 2015-07-14 2022-06-08 The Research Institute at Nationwide Children's Hospital Novel formulation for the elimination of cariogenic and opportunistic pathogens within the oral cavity
ES2551053B1 (es) * 2015-07-31 2016-09-06 Fertypharm, S.L. Complemento alimenticio polivitamínico para mujeres embarazadas
US11564667B2 (en) 2015-12-28 2023-01-31 New York University Device and method of restoring microbiota of newborns
AU2017251028A1 (en) * 2016-04-13 2018-11-29 Meiji Co., Ltd. Brain function-improving composition for newborns
EP4238573A1 (en) 2016-04-15 2023-09-06 Baylor College of Medicine Lactobacillus reuteri mm4-1a for use in the treatment or prevention of autism spectrum disorders
CN109310716A (zh) * 2016-07-01 2019-02-05 雀巢产品技术援助有限公司 用于预防和/或治疗哺乳动物的焦虑症及相关病症的包含益生菌的营养组合物
MX2020003198A (es) * 2017-09-29 2020-10-12 Univ Industry Cooperation Group Kyung Hee Univ Bacterias acidolácticas novedosas y uso de las mismas.
WO2020247536A1 (en) * 2019-06-03 2020-12-10 Research Institute At Nationwide Children's Hospital Prebiotic formulations for prevention of sepsis and necroenterocolitis induced neurodevelopmental deficiencies
JP6739602B1 (ja) 2019-07-24 2020-08-12 雪印メグミルク株式会社 記憶・学習能維持および／または向上用組成物及び組成物を含む食品、医薬品、飼料
CN111073828B (zh) * 2019-11-19 2022-04-15 江南大学 一种长双歧杆菌长亚种及其应用
CN111658676B (zh) * 2020-06-11 2021-12-31 湖州金诺康健康科技有限公司 罗伊氏乳杆菌活菌在制备治疗或减轻非酒精性脂肪肝症状的药物中的应用
CN114098084A (zh) * 2021-04-13 2022-03-01 中国人民解放军军事科学院军事医学研究院 一种缓解长期低剂量辐射暴露所致认知损伤的益生菌组合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20010763A1 (it) * 2001-12-21 2003-06-21 Simone Claudio De Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.
EP2147678A1 (en) * 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
EP2251030A1 (en) * 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and brain health and development in infants
IT1401460B1 (it) * 2010-06-11 2013-07-26 Probiotical Spa "ceppi di batteri probiotici produttori di vitamina b12"

Also Published As

Publication number Publication date
CN104185427A (zh) 2014-12-03
ZA201404824B (en) 2015-09-30
WO2013098033A1 (en) 2013-07-04
AU2012361122A1 (en) 2014-07-17
EP2609814A1 (en) 2013-07-03
BR112014015826A8 (pt) 2017-07-04
MX2014008099A (es) 2014-09-26
JP2015503913A (ja) 2015-02-05
RU2014131382A (ru) 2016-02-20
EP2797434A1 (en) 2014-11-05
US20140363410A1 (en) 2014-12-11
CA2862001A1 (en) 2013-07-04
BR112014015826A2 (pt) 2017-06-13
KR20140131505A (ko) 2014-11-13

Similar Documents

Publication Publication Date Title
HK1203767A1 (en) Lactobacillus reuteri dsm 17938 for the development of cognitive function dsm17938
HK1203315A1 (en) Lactobacillus reuteri dsm 17938 for the development of the enteric nervous system dsm17938
HUE038637T2 (hu) Eljárás a diaril-tiohidantoin és a diaril-hidantoin vegyületek szintetizálására
PL2626076T3 (pl) Zastosowania terapeutyczne Lactobacillus salivarius LS01 DSM 22775
ZA201301178B (en) Compounds for the reduction of beta-amyloid production
HK1193947A1 (zh) 香味增強的鼠李糖乳桿菌
HK1179608A1 (zh) 利福昔明的晶型及其用途
ZA201208770B (en) New forms of rifaximin and uses thereof
SG10201703051WA (en) Compounds and methods for the production of suckerin and uses thereof
EP2303295A4 (en) CONTROLLED ACTIVATION OF THE REUTERIN PRODUCTION MACHINERY BY LACTOBACILLUS REUTERI
PL2423395T3 (pl) Uszczelnienie podłogi prysznica
GB201114642D0 (en) Toner processes
EP2613200A4 (en) TONER AND MANUFACTURING METHOD THEREFOR
EP2567936A4 (en) METHOD OF OBTAINING NANO-COMPOSITE MATERIALS
PL2648833T3 (pl) Zespół do wytwarzania dyspersji
EP2581375A4 (en) IMPROVED METHODS FOR THE PREPARATION OF QUINOXALINE DERIVATIVES
GB201020357D0 (en) Compounds and methods of making the same
ZA201404825B (en) Lactobacillus reuteri dsm 17938 for the development of the enteric nervous system
PL119455U1 (pl) Zespół grzyba zaworu balansowego
EP2776566A4 (en) COMPOUNDS FOR MODULATING BETA-CATENIN EXPRESSION AND USES THEREOF
GB201016854D0 (en) Annular seals
GB201007519D0 (en) Means for inhibiting the expression of rragb
GB201000627D0 (en) Laptop 360
PL391377A1 (pl) Konstrukcja mebla do leżenia
GB201013867D0 (en) Pte 8